The Tetanus drugs in development market research report provides comprehensive information on the therapeutics under development for Tetanus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Tetanus. Buy the report here.
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Tetanus and features dormant and discontinued products.
GlobalData tracks 50 drugs in development for Tetanus by 32 companies/universities/institutes. The top development phase for Tetanus is preclinical with 17 drugs in that stage. The Tetanus pipeline has 48 drugs in development by companies and two by universities/ institutes. Some of the companies in the Tetanus pipeline products market are: CanSino Biologics, AIM Vaccine and Serum Institute of India.
The key targets in the Tetanus pipeline products market include Tetanus Toxin, Pertussis Toxin, and Diphtheria Toxin.
The key mechanisms of action in the Tetanus pipeline product include Tetanus Toxin Inhibitor with one drug in Phase III. The Tetanus pipeline products include three routes of administration with the top ROA being Intramuscular and eight key molecule types in the Tetanus pipeline products market including Toxoid Vaccine, and Inactivated Vaccine.
Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever, sweating, elevated blood pressure, and rapid heart rate. The predisposing factors include burns, surgical wounds, ear infections, swelling around the injury, and infected foot ulcers. Treatment includes antibiotics, sedatives, and beta blockers.
For a complete picture of Tetanus’s pipeline drug market, buy the report here.